Look at a transcatheter mitral valve repair technology advancing treatment for functional mitral regurgitation and global clinical adoption.
Key Takeaways
- Device received CE mark approval in the EU for functional mitral regurgitation
- One-year data showed 86.7% achieved the composite primary effectiveness endpoint
- Procedural and device implantation success rates reached 97.4% in the pivotal study